Jazz

AI Medical

Key Features

Brain lesion detection
Volume quantification

General Information

Product name

Jazz

Company

AI Medical

Subspeciality

Neuro

Modality

Disease targeted

Multiple sclerosis (MS), brain metastasis

Main task

Not specified

Technical Specifications

Population

Patients with known diagnosis of multiple sclerosis or brain metastasis

Patient population age

Not specified

Input

Any brain MRI

Input format

DICOM

Output

Report with user prefered items such as evolution, anatomical position, mcDonald criteria (for MS), lesion treatment (for metastasis), etc

Output format

DICOM, Pdf, Rtf

Integration

Integration CIS (Clinical Information System), Integration in standard reading environment (PACS), Integration RIS (Radiological Information System)

Deployment

Locally on dedicated hardware

Trigger for analysis

Automatically, Right after the image acquisition

Processing time

3 - 10 seconds

Regulatory Information

CE Certification

Pathway:

MDR

Class:

Class IIa

Verified by Health AI Register

FDA Certification

Pathway:

510(k) cleared

Class:

Class II

Verified by Health AI Register

Other certifications

Not specified

Market Presence

On market since

02-2023

AI Platforms

Not specified

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Subscription

Based on

Not specified

Evidence & Research

Peer-Reviewed Papers

Peer-Reviewed

View

Evaluation of the quality and the productivity of neuroradiological reading of multiple sclerosis follow-up MRI scans using an intelligent automation software

Technical Papers

Technical

View

Improved Detection, Description and Efficiency of Multiple Sclerosis Neuroradiological Lesions’ Assessment using a Semi-Automatic Dedicated Deep-Learning Based Software Jazz

Source: vendor | First published: Mar 24, 2024 | Last updated: Jul 9, 2025